Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated the effectiveness of a triple fixed-dose combination of Dapagliflozin, Sitagliptin, and Metformin compared to a dual combination of Sitagliptin and Metformin in managing Type 2 Diabetes.
This study investigated the effects of short-term hyperglycemia from insulin discontinuation on myocardial contractile function in type 2 diabetic patients, finding significant improvements in several cardiac metrics.
This study evaluated the effects of empagliflozin as an adjunct to insulin in patients with type 1 diabetes, showing significant reductions in blood sugar levels and insulin doses.
This study investigated the pharmacodynamic properties of insulin analogs detemir and glargine in severely obese patients with type 2 diabetes, revealing significant increases in glucose infusion rates.
This study evaluated the impact of an interactive virtual assistant device on mental health and diabetes management in older adults with diabetes, finding significant improvements in several outcomes.
This study evaluated the impact of nurse-led diabetic follow-up clinics on glycemic control in Type 2 diabetes patients, finding significant improvements in HbA1c levels and treatment satisfaction.
This study investigated the effect of metformin on insulin requirements in pregnant women with type 1 diabetes, finding a significant reduction in prandial insulin needs.
This study explored the impact of non-surgical periodontal therapy on glycemic control in individuals with type 2 diabetes and periodontitis, finding a significant reduction in HbA1c levels.
The study investigated the addition of vildagliptin to premixed insulin therapy in patients with type 2 diabetes, finding significant improvements in glycemic control.
This study evaluated the effectiveness of β-glucan-enriched bread on glycemic control in adults at risk of type 2 diabetes, finding no significant differences in key outcomes.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
